HekaHeart Phase 1 Proof of Concept

HekaHeart Phase 1 Proof of Concept

Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: Device: HekaHeart platform medication management and remote monitoring
Sponsors: Yale University; Roivant Sciences (HekaHeart)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 31, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments